Europe Transfection Reagents and Equipment Market - Industry Trends and Forecast to 2030

Description

List of Tables

Europe transfection reagent and equipment market is projected to register a substantial CAGR of 8.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation:

Europe Transfection Reagents and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Transfection Reagents and Equipment, Stable Transfection Reagents, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (By Type and By Industry), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Belgium, Ireland, Poland, and Rest of Europe) Industry Trends and Forecast to 2030

Some of the drivers that boost transfection reagents and equipment market's growth are as follows:

Rise in the prevalence of chronic diseases

Utilization of biopharmaceuticals for protein production

Market Players:

Some of the major players operating in the Europe transfection reagents and equipment market are:

Mirus Bio LLC.

Promega Corporation

Polyplus Transfection

Bio-Rad Laboratories, Inc.

Merck KGaA

Lonza

MaxCyte, Inc.

PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)

Cytiva

R&D Systems, Inc.

Takara Bio Inc.

OriGene Technologies, Inc.

Beckman Coulter, Inc. (A Subsidiary of Danaher)

SignaGen Laboratories

1 INTRODUCTION 18

1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 OVERVIEW OF THE EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET 18
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 22

2 MARKET SEGMENTATION 28

2.1 MARKETS COVERED 28
2.2 GEOGRAPHICAL SCOPE 29
2.3 YEARS CONSIDERED FOR THE STUDY 30
2.4 CURRENCY AND PRICING 30
2.5 DBMR TRIPOD DATA VALIDATION MODEL 31
2.6 MULTIVARIATE MODELLING 34
2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE 34
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.9 DBMR MARKET POSITION GRID 36
2.10 MARKET APPLICATION COVERAGE GRID 37
2.11 VENDOR SHARE ANALYSIS 38
2.12 SECONDARY SOURCES 39
2.13 ASSUMPTIONS 39

3 EXECUTIVE SUMMARY 40

4 PREMIUM INSIGHT 43

4.1 PESTEL 44
4.2 PORTER'S FIVE FORCES MODEL 45

5 INDUSTRY INSIGHTS: 46

6 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET, REGULATIONS 47

6.1 EUROPEAN UNION REGULATORY SCENARIO 47
6.2 U.S. REGULATORY SCENARIO 48
6.3 JAPAN REGULATORY SCENARIO 48
6.4 CHINA REGULATORY SCENARIO 49

7 MARKET OVERVIEW 51

7.1 DRIVERS 53
- 7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES 53
- 7.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS 54
- 7.1.3 GROWING DEMAND FOR CHIMERIC GENES 54
- 7.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH 55
- 7.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS 55
7.2 RESTRAINTS 56
- 7.2.1 HIGH COST OF TRANSFECTION PRODUCTS 56
- 7.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS 56
- 7.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE 57
7.3 OPPORTUNITIES 57
- 7.3.1 EXPLORATION OF EMERGING MARKET 57
- 7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 58
- 7.3.3 SURGING LEVEL OF INVESTMENT 59
7.4 CHALLENGES 59
- 7.4.1 LONG APPROVAL PROCEDURE 59
- 7.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS-ASSOCIATED TRANSFECTION 60
- 7.4.3 LACK OF TRAINED PROFESSIONALS 61

8 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS 62

8.1 OVERVIEW 63
8.2 REAGENTS & KITS 66
8.3 INSTRUMENTS 67

9 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE 69

9.1 OVERVIEW 70
9.2 RESEARCH 73
9.3 PRECLINICAL 73
9.4 CLINICAL PHASES 74
9.5 COMMERCIAL 75

10 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE 77

10.1 OVERVIEW 78
10.2 TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT 81
10.3 STABLE TRANSECTION REAGENTS AND EQUIPMENT 81

11 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY METHODS 83

11.1 OVERVIEW 84
11.2 NON-VIRAL METHODS 87
11.3 VIRAL METHODS 87

12 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE 89

12.1 OVERVIEW 90
12.2 PLASMID DNA 92
12.3 SMALL INTERFERING RNA (SIRNA) 93
12.4 PROTEINS 94
12.5 DNA OLIGONUCLEOTIDES 95
12.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS) 96
12.7 OTHERS 96

13 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM 98

13.1 OVERVIEW 99
13.2 MAMMALIAN CELLS 101
13.3 PLANTS 102
13.4 FUNGI 103
13.5 VIRUS 104
13.6 BACTERIA 105

14 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY APPLICATION 106

14.1 OVERVIEW 107
14.2 IN VITRO APPLICATION 109
- 14.2.1 IN VIVO APPLICATION 111
- 14.2.2 BIOPRODUCTION 112
- 14.2.3 OTHERS 112
- 14.2.4 SYNTHETIC BIOLOGY 113
- 14.2.5 AGRICULTURE 113
- 14.2.6 OTHERS 113

15 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER 114

15.1 OVERVIEW 115
15.2 BIOPHARMA 118
15.3 CROS 118
15.4 CMOS/CDMOS 119
15.5 ACADEMIA 120
15.6 HOSPITALS 121
15.7 CLINICAL LABS 122
15.8 OTHERS 123

16 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL 124

16.1 OVERVIEW 125
16.2 DIRECT TENDER 128
16.3 RETAIL SALES 129
16.4 OTHERS 130

17 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION 131

17.1 EUROPE 132
- 17.1.1 GERMANY 138
- 17.1.2 U.K. 138
- 17.1.3 FRANCE 138
- 17.1.4 ITALY 138
- 17.1.5 RUSSIA 138
- 17.1.6 SPAIN 138
- 17.1.7 TURKEY 138
- 17.1.8 NETHERLANDS 138
- 17.1.9 BELGIUM 138
- 17.1.10 SWITZERLAND 138
- 17.1.11 REST OF EUROPE 138

18 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE 139

18.1 COMPANY SHARE ANALYSIS: EUROPE 139

19 SWOT ANALYSIS 140

20 COMPANY PROFILE 141

20.1 THERMO FISHER SCIENTIFIC INC. 141
- 20.1.1 COMPANY SNAPSHOT 141
- 20.1.2 REVENUE ANALYSIS 141
- 20.1.3 COMPANY SHARE ANALYSIS 142
- 20.1.4 PRODUCT PORTFOLIO 142
- 20.1.5 RECENT DEVELOPMENT 143
20.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD) 144
- 20.2.1 COMPANY SNAPSHOT 144
- 20.2.2 REVENUE ANALYSIS 144
- 20.2.3 COMPANY SHARE ANALYSIS 145
- 20.2.4 PRODUCT PORTFOLIO 145
- 20.2.5 RECENT DEVELOPMENT 146
20.3 PROMEGA CORPORATION 147
- 20.3.1 COMPANY SNAPSHOT 147
- 20.3.2 COMPANY SHARE ANALYSIS 147
- 20.3.3 PRODUCT PORTFOLIO 148
- 20.3.4 RECENT DEVELOPMENT 148
20.4 TAKARA BIO INC. 149
- 20.4.1 COMPANY SNAPSHOT 149
- 20.4.2 REVENUE ANALYSIS 149
- 20.4.3 COMPANY SHARE ANALYSIS 150
- 20.4.4 PRODUCT PORTFOLIO 150
- 20.4.5 RECENT DEVELOPMENT 150
20.5 BIO-RAD LABORATORIES, INC. 151
- 20.5.1 COMPANY SNAPSHOT 151
- 20.5.2 REVENUE ANANLYSIS 151
- 20.5.3 COMPANY SHARE ANALYSIS 152
- 20.5.4 PRODUCT PORTFOLIO 152
- 20.5.5 RECENT DEVELOPMENT 153
20.6 ALTOGEN BIOSYSTEMS 154
- 20.6.1 COMPANY SNAPSHOT 154
- 20.6.2 PRODUCT PORTFOLIO 154
- 20.6.3 RECENT DEVELOPMENT 155
20.7 APPLIED BIOLOGICAL MATERIALS INC. (ABM) 156
- 20.7.1 COMPANY SNAPSHOT 156
- 20.7.2 PRODUCT PORTFOLIO 156
- 20.7.3 RECENT DEVELOPMENT 156
20.8 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC) 157
- 20.8.1 COMPANY SNAPSHOT 157
- 20.8.2 REVENUE ANALYSIS 157
- 20.8.3 PRODUCT PORTFOLIO 158
- 20.8.4 RECENT DEVELOPMENT 158
20.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER) 159
- 20.9.1 COMPANY SNAPSHOT 159
- 20.9.2 PRODUCT PORTFOLIO 159
- 20.9.3 RECENT DEVELOPMENT 159
20.10 CYTIVA 160
- 20.10.1 COMPANY SNAPSHOT 160
- 20.10.2 PRODUCT PORTFOLIO 160
- 20.10.3 RECENT DEVELOPMENT 160
20.11 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION) 161
- 20.11.1 COMPANY SNAPSHOT 161
- 20.11.2 REVENUE ANANLYSIS 161
- 20.11.3 PRODUCT PORTFOLIO 162
- 20.11.4 RECENT DEVELOPMENT 162
20.12 GENLANTIS INC. 163
- 20.12.1 COMPANY SNAPSHOT 163
- 20.12.2 PRODUCT PORTFOLIO 163
- 20.12.3 RECENT DEVELOPMENT 163
20.13 GENO TECHNOLOGY INC., USA 164
- 20.13.1 COMPANY SNAPSHOT 164
- 20.13.2 PRODUCT PORTFOLIO 164
- 20.13.3 RECENT DEVELOPMENT 164
20.14 GINKGO BIOWORKS 165
- 20.14.1 COMPANY SNAPSHOT 165
- 20.14.2 PRODUCT PORTFOLIO 165
- 20.14.3 RECENT DEVELOPMENTS 165
20.15 LONZA 166
- 20.15.1 COMPANY SNAPSHOT 166
- 20.15.2 REVENUE ANANLYSIS 166
- 20.15.3 PRODUCT PORTFOLIO 167
- 20.15.4 RECENT DEVELOPMENT 167
20.16 MAXCYTE, INC. 168
- 20.16.1 COMPANY SNAPSHOT 168
- 20.16.2 REVENUE ANALYSIS 168
- 20.16.3 PRODUCT PORTFOLIO 169
- 20.16.4 RECENT DEVELOPMENT 169
20.17 MERCK KGAA 170
- 20.17.1 COMPANY SNAPSHOT 170
- 20.17.2 REVENUE ANALYSIS 170
- 20.17.3 PRODUCT PORTFOLIO 171
- 20.17.4 RECENT DEVELOPMENT 171
20.18 MIRUS BIO LLC. 172
- 20.18.1 COMPANY SNAPSHOT 172
- 20.18.2 PRODUCT PORTFOLIO 172
- 20.18.3 RECENT DEVELOPMENT 172
20.19 ORIGENE TECHNOLOGIES, INC. 174
- 20.19.1 COMPANY SNAPSHOT 174
- 20.19.2 PRODUCT PORTFOLIO 174
- 20.19.3 RECENT DEVELOPMENT 174
20.20 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.) 175
- 20.20.1 COMPANY SNAPSHOT 175
- 20.20.2 REVENUE ANALYSIS 175
- 20.20.3 PRODUCT PORTFOLIO 176
- 20.20.4 RECENT DEVELOPMENT 176
20.21 POLYPLUS TRANSFECTION 177
- 20.21.1 COMPANY SNAPSHOT 177
- 20.21.2 PRODUCT PORTFOLIO 177
- 20.21.3 RECENT DEVELOPMENT 177
20.22 R&D SYSTEMS, INC. 179
- 20.22.1 COMPANY SNAPSHOT 179
- 20.22.2 PRODUCT PORTFOLIO 179
- 20.22.3 RECENT DEVELOPMENT 179
20.23 SBS GENETECH 180
- 20.23.1 COMPANY SNAPSHOT 180
- 20.23.2 PRODUCT PORTFOLIO 180
- 20.23.3 RECENT DEVELOPMENT 180
20.24 SIGNAGEN LABORATORIES 181
- 20.24.1 COMPANY SNAPSHOT 181
- 20.24.2 PRODUCT PORTFOLIO 181
- 20.24.3 RECENT DEVELOPMENT 181

21 QUESTIONNAIRE 183

22 RELATED REPORTS 188

LIST OF TABLES

TABLE 1 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS, 2021-2030 (USD THOUSAND) 65
TABLE 2 EUROPE REAGENT AND KITS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
TABLE 3 EUROPE INSTRUMENTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
TABLE 4 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE, 2021-2030 (USD THOUSAND) 72
TABLE 5 EUROPE RESEARCH IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
TABLE 6 EUROPE PRECLINICAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 74
TABLE 7 EUROPE CLINICAL PHASES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
TABLE 8 EUROPE COMMERCIAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
TABLE 9 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 80
TABLE 10 EUROPE TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
TABLE 11 EUROPE STABLE TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
TABLE 12 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2021-2030 (USD THOUSAND) 86
TABLE 13 EUROPE NON-VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
TABLE 14 EUROPE VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 88
TABLE 15 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE, 2021-2030 (USD THOUSAND) 92
TABLE 16 EUROPE PLASMID DNA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 93
TABLE 17 EUROPE SMALL INTERFERING RNA (SIRNA) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 94
TABLE 18 EUROPE PROTEINS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
TABLE 19 EUROPE DNA OLIGONUCLEOTIDES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
TABLE 20 EUROPE RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
TABLE 21 EUROPE OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
TABLE 22 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM, 2021-2030 (USD THOUSAND) 101
TABLE 23 EUROPE MAMMALIAN CELLS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 102
TABLE 24 EUROPE PLANTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
TABLE 25 EUROPE FUNGI IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
TABLE 26 EUROPE VIRUS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 104
TABLE 27 EUROPE BACTERIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 105
TABLE 28 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET , BY APPLICATION, 2021-2030 (USD THOUSAND) 109
TABLE 29 EUROPE IN VITRO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 111
TABLE 30 EUROPE IN VIVO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 112
TABLE 31 EUROPE BIOPRODUCTION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 112
TABLE 32 EUROPE OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 113
TABLE 33 EUROPE APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY INDUSTRY, 2021-2030 (USD THOUSAND) 113
TABLE 34 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 117
TABLE 35 EUROPE BIOPHARMA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 118
TABLE 36 EUROPE CROS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 119
TABLE 37 EUROPE CMOS/CDMOS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 120
TABLE 38 EUROPE ACADEMIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 121
TABLE 39 EUROPE HOSPITALS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 122
TABLE 40 EUROPE CLINICAL LABS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 123
TABLE 41 EUROPE OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 123
TABLE 42 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 127
TABLE 43 EUROPE DIRECT TENDER IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 128
TABLE 44 EUROPE RETAIL SALES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 129
TABLE 45 EUROPE OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 130

LIST OF FIGURES

FIGURE 1 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION 26
FIGURE 2 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DATA TRIANGULATION 29
FIGURE 3 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DROC ANALYSIS 30
FIGURE 4 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 31
FIGURE 5 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS 31
FIGURE 6 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MULTIVARIATE MODELLING 32
FIGURE 7 EUROPE TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS 33
FIGURE 8 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DBMR MARKET POSITION GRID 34
FIGURE 9 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID 35
FIGURE 10 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: VENDOR SHARE ANALYSIS 36
FIGURE 11 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION 40
FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2022 TO 2030 41
FIGURE 13 THE TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN 2022 & 2030 41
FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA 48
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET 50
FIGURE 16 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023 61
FIGURE 17 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023-2030 (USD THOUSAND) 62
FIGURE 18 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, CAGR (2023-2030) 62
FIGURE 19 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, LIFELINE CURVE 63
FIGURE 20 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023 68
FIGURE 21 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023-2030 (USD THOUSAND) 69
FIGURE 22 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, CAGR (2023-2030) 69
FIGURE 23 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, LIFELINE CURVE 70
FIGURE 24 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023 76
FIGURE 25 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023-2030 (USD THOUSAND) 77
FIGURE 26 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, CAGR (2023-2030) 77
FIGURE 27 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE 78
FIGURE 28 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2022 82
FIGURE 29 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2023-2030 (USD THOUSAND) 83
FIGURE 30 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, CAGR (2023-2030) 83
FIGURE 31 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, LIFELINE CURVE 84
FIGURE 32 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2022 88
FIGURE 33 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2023-2030 (USD THOUSAND) 89
FIGURE 34 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, CAGR (2023-2030) 89
FIGURE 35 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, LIFELINE CURVE 90
FIGURE 36 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2022 97
FIGURE 37 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2023-2030 (USD THOUSAND) 98
FIGURE 38 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, CAGR (2023-2030) 98
FIGURE 39 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, LIFELINE CURVE 99
FIGURE 40 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2022 105
FIGURE 41 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2023-2030 (USD THOUSAND) 106
FIGURE 42 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, CAGR (2023-2030) 106
FIGURE 43 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, LIFELINE CURVE 107
FIGURE 44 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY END USER, 2022 113
FIGURE 45 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, 2023-2030 (USD THOUSAND) 114
FIGURE 46 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, CAGR (2023-2030) 114
FIGURE 47 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, LIFELINE CURVE 115
FIGURE 48 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2022 123
FIGURE 49 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 124
FIGURE 50 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 124
FIGURE 51 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 125
FIGURE 52 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022) 131
FIGURE 53 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022) 133
FIGURE 54 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030) 133
FIGURE 55 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (202 & 2030) 134
FIGURE 56 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030) 135
FIGURE 57 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%) 137